The independent source for health policy research, polling, and news.
741-760 of 1,294 results
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government鈥檚 preeminent health agencies 鈥 the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health 鈥 are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss this and more. Plus, Rovner interviews KHN鈥檚 Elizabeth Lawrence about the latest KHN-NPR 鈥淏ill of the Month鈥 installment.
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
The proposal details a wide-ranging agenda to remedy the gaps in health care and myriad challenges in rural America. In addition to more telehealth options, it includes shifts in hospital payments and expanded funding for school-based mental health programs.
Donald Trump accepted his party's nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
President Donald Trump touted the Food and Drug Administration鈥檚 approval of this unproven COVID-19 treatment for emergency use. That set off reactions ranging from excitement and optimism to scientific concerns and criticism that the decision was politically motivated.
Early in the pandemic, Trump feuded with governors over whose responsibility it was to secure supplies and states sometimes found themselves competing with each other and the federal government for scarce personal protective equipment and testing materials.
Vice President Mike Pence officially accepted the Republican Party's nomination for a second term.
Tuesday night's speakers offered positive views on President Donald Trump's handling of the pandemic. The first lady and Trump, himself, took advantage of the trappings of the White House in setting the scene.
During his Monday speech at the Republican National Convention, President Donald Trump pointed to his two of his recent executive orders as likely to lead to big reductions in prescription drug costs.
In a highly produced, made-for-TV political convention, Democrats papered over their differences on a variety of issues, including health care, to show a unified front to defeat President Donald Trump in November. Meanwhile, COVID-19 continues to complicate efforts to get students back to school, and a federal judge blocks the Trump administration鈥檚 efforts to eliminate anti-discrimination protections for transgender people. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Shefali Luthra of The 19th join KHN鈥檚 Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Democrats continued the virtual extravaganza. Health care was a hot topic.
The coronavirus was a critical theme throughout the evening.
The Democratic presidential ticket is complete, with Joe Biden鈥檚 selection of California Sen. Kamala Harris as his running mate. Health has not been a major issue for Harris, whose career priority has been the criminal justice system. But expect Republicans to pounce on her on-again, off-again support for 鈥淢edicare for All.鈥 Meanwhile, with Congress still in a stalemate over another round of COVID-19 relief, President Donald Trump is trying to use his executive power to do what lawmakers have not 鈥 with mixed success. Kimberly Leonard of Business Insider, Joanne Kenen of Politico and Mary Agnes Carey of KHN join KHN鈥檚 Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Even before he was elected, the president talked about a plan that would be released soon. Now he is saying the end of August.
President Donald Trump keeps promising a comprehensive plan to replace the Affordable Care Act. And he keeps not delivering. Meanwhile, members of Congress and White House officials seem unable to agree on a new COVID-19 relief bill. And Missouri becomes the sixth state where voters approved a Medicaid expansion ballot measure. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Kimberly Leonard of Business Insider join KHN鈥檚 Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Experts say aid from certain veterinary labs could relieve some of the pressure on commercial and hospital-based labs to lessen the current delays in COVID-19 testing and results, but it is unlikely to be a game changer.
President Donald Trump鈥檚 sobering view of COVID-19 didn鈥檛 last long 鈥 this week, he was back to pushing hydroxychloroquine, a drug that has been shown not to work in treating the virus. Meanwhile, Republicans on Capitol Hill are still scrambling to agree among themselves and with the White House on the next coronavirus relief bill, as both a moratorium on evictions and extra unemployment payments expire. And the debate over drug prices, which was going to be one of the biggest health issues of this election year, makes a brief appearance. Alice Miranda Ollstein of Politico, Mary Ellen McIntire of CQ Roll Call and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 story about a surprise bill from a surprise surgical assistant.
The FDA must approve any coronavirus vaccine before it鈥檚 widely distributed, but political pressure could cloud the decision.
漏 2026 KFF